Not yet taking people in Lettország1. fázis
A PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO- CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND BIOLOGICAL ACTIVITY OF TQS-168 IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS
Key facts
- Where
- Riga, LettországSee the site
- Phase
- 1. fázis
Where in Lettország
- Pauls Stradins Clinical University HospitalRiga, LettországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tranquis Therapeutics Inc.
- Trial code
- EU 2023-504746-54-00
- Record updated
- 2023. október 11.